Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Conditions

Warts 2

Interventions

N-phenylacetoaminomethylene-DL-p-nitrophenylalanine 22-Propanol 2methyl 5-aminolevulinate 1Zinc Sulfate 1Vaccination 1VP-102 1Tuberculin 1Photochemotherapy 1PRA1 protein, Candida albicans 1Exercise 1Cantharidin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Warts × 2-Propanol × Clear all
NCT03691831 2020-10-27

A Study of A-101 Topical Solution for the Treatment of Common Warts

Aclaris Therapeutics, Inc.

Phase 3 Completed
502 enrolled 22 charts

Warts

NCT03687372 2020-10-05

Study of A-101 Topical Solution for the Treatment of Common Warts

Aclaris Therapeutics, Inc.

Phase 3 Completed
503 enrolled 22 charts

Warts

Data powered by HemOnc (CC BY 4.0) Colophon âš¡